Parents
Conditions
Keywords
Mexican, Mexican-American, 17-336
Brief summary
This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.
Interventions
BEHAVIORALHPV Vaccine Education
A one on one twenty-minute parental educational program (in-person or over the phone) providing facts about HPV, HPV-related cancers, and the HPV vaccine.
BEHAVIORALText Messaging Reminder
Participants will receive a text message reminding them of their child's vaccination eligibility once a week, starting one week after participating in the education session (in-person or over the phone). All participants randomized to the text message reminder arm will receive a welcome text message from the automated web-based text messaging service, Mosio, within 72 hours from registration. One week after receiving the welcome text message, they will receive the first weekly text messages reminding them of their child's eligibility for the first dose HPV vaccine. These weekly reminders will occur until uptake of the first dose of the vaccine is reported (through self-report outcome survey completion or submission of the HPV vaccination card/child's official immunization card) or for up to 12 weeks
Sponsors
Memorial Sloan Kettering Cancer Center
Hackensack Meridian Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 84 Years
Healthy volunteers
Yes
Inclusion criteria
* Born in Mexico or born in U.S. but self-describes as Mexican-American * Spanish is his or her primary language * Has a minimum of one child between the ages of 11 and 17 who has not initiated or completed the HPV vaccine seriest (as per the age-recommended timeframe) * Self-identifies as the child's main caregiver * Currently owns a cell phone and uses text messaging services and is willing to accept text messages for this study * 21 to 84 years old
Exclusion criteria
* Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vaccination completion assessment rate | 2 years | Comparison rates of vaccination completion will be assessed by Fisher's exact test. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORFrancesca Gany, MD, MS
Memorial Sloan Kettering Cancer Center
Outcome results
None listed